In this short video, Michael Kostrzewa (Baden, Switzerland) and Rashid Akhtar (London, UK) discuss the latest approaches to the treatment of acute pulmonary embolism (PE) and deep vein thrombosis (DVT) using mechanical thrombectomy.
They examine which patients are eligible...
In conversation with Venous News at Paris Vascular Insights (PVI) 2023 (8–10 November, Paris, France), Michael Lichtenberg (Arnsberg, Germany) spoke at length on the state of play in the venous field.
The chief medical officer and director of the Angiology Department and...
Experience wall-to-wall thrombectomy in action with Manuela Konert from Leipzig, Germany! In this brief video, Konert walks through a deep vein thrombosis (DVT) case step by step using the ClotTriever system, providing valuable clinical insights along the way. Highlighting...
In a recent interview, Marie Josee van Rijn from Rotterdam, the Netherlands and Emma Wilton from Oxford, UK, provided insight into the transformative power of interventional approaches in the treatment of DVT. They also set the stage for the...
NOTE: This video is ONLY available to watch in selected countries and geographies
David Dexter, (Sentara Vascular Specialists, Norfolk, USA, National Co-PI of the CLOUT registry) speaks on recently presented one-year outcomes from the 500 patient CLOUT registry (NCT03575364)....
“The median thrombus age of DVT patients treated in our centre is 14 days – says Dr Andrew Wigham from Oxford University Hospitals. – We know that traditional treatment options such as thrombolytics and other thrombectomy devices are less...
In an interview with Venous News at this year’s Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany), Raghu Kolluri (Columbus, USA) outlined the “vast list” of options that are now available for the treatment of patients who require...
Why is clot removal crucial for patients suffering from DVT? What are the major benefits of a lytic-free thrombectomy? Watch Michael Lichtenberg (Arnsberg, Germany) present the outcomes of the Arnsberg ClotTriever Study which confirms the safety and efficacy of...
“I see a future where this technology may be used to treat people early and avoid the devastating long term consequences of venous insufficiency” Ramon Varcoe (Sydney, Australia) opined in a CX Vascular Live discussion with Erin Murphy (Charlotte,...
Steven Abramowitz (Washington DC, USA) explains the significance of the CLOUT registry—the only registry capturing data on mechanical thrombectomy in deep venous thrombosis (DVT). CLOUT confirms excellent safety results and effectiveness of the ClotTriever system in real-world DVT patients....
“Superficial venous treatments have come a long way in the last 20 years,” Manj Gohel (Cambridge, UK) tells Venous News, before outlining the key aims of the VenaSeal Spectrum programme—which includes three studies (two randomised and one prospective observational...
Speaking to Venous News at VEITHsymposium 2022 (15–19 November, New York, USA) Armando Mansilha (Porto, Portugal) answers the “challenging question” of how to best approach selecting an appropriate care pathway for patients with superficial venous disease. Offering a range...
Stephen Black (London, UK) talks to Venous News about the key 36-month results from the ABRE study, which evaluated the safety and effectiveness of the Abre venous self-expanding stent system for the treatment of symptomatic iliofemoral venous outflow obstruction in patients with...
NOTE: This video is ONLY available to watch in selected countries and geographies
Iliac side branch devices (ISBs) are “gamechangers in infrarenal therapy of abdominal aortic aneurysms (AAAs),” Mario Lescan (Tübingen, Germany) tells Vascular News. Lescan states that ISBs “allow...
Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain) about some of the difficulties associated with treating patients with pulmonary embolism...
John White (Chicago, USA) talks to Venous News at this year’s European Society for Vascular Surgery annual meeting (ESVS 2022; 20–23 September, Rome, Italy), about a procedure that is designed to help treat women who suffer from chronic pelvic...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) discuss the current state of deep vein thrombosis (DVT) treatment at the Leipzig Interventional Course (LINC) 2022 (6–9 June, Leipzig, Germany), with both noting that “a massive problem” in...
Venous care in the UK is in a “sorry state at the moment”, Zola Mzimba (Derry, UK) tells Venous News. This is in part down to COVID-19 which has driven a continued rise in waiting lists and patient assessments. However,...
Catherine Arundel (York, UK) talks to Venous News at the UK Vascular Societies’ Annual Scientific Meeting (VSASM 2021; 1–3 December, Manchester, UK) about the VenUS-6 trial—a randomised controlled trial which aims to recruit and randomise 675 people with venous...
Rachael Morris (London, UK) talks to Venous News about VEINES QoL/Sym—a venous disease-specific quality of life (QoL) questionnaire for patients with chronic venous insufficiency—as well as the findings of a study which sought to evaluate changes in venous-specific QoL...
Venous stenting can have myriad benefits for carefully selected patients with deep and pelvic venous disease. However, as venous stenting has quickly gained popularity, concerns have arisen about the appropriateness of its use and the potential complications that may occur.
Rick...
Michael Lichtenberg (Karolinen Hospital, Arnsberg, Germany) details three-year data from the Arnsberg venous registry on the VICI Venous Stent System (Boston Scientific).
This video forms part of a digital advertorial sponsored by Boston Scientific.
Mahmood Razavi (Orange, USA) speaks to Venous News about the recently initiated VIVID trial – a prospective, multicentre, single-arm study which has just begun enrolment and is designed to evaluate the safety and efficacy of the Vesper DUO Venous Stent System in the...
Anthony Comerota (Alexandria, USA), global principal investigator of the VIVO trial, discusses the highlights of the 12-month results of the VIVO clinical study that were presented at VIVA 2020.
While the safety and efficacy of the Zilver Vena stent, which...
Venous News takes a look back at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) where Stephen Black (London, UK) and Mitchell Silver (Columbus, USA) discuss the CLEAR-DVT study.
Silver touches on some of the “historic studies” of venous intervention such as ATTRACT and CaVenT and compares them to CLEAR-DVT, which he...
Manj Gohel (Cambridge, UK) is joined by a host of venous experts including Beverley Hunt (London, UK), Stephen Black (London, UK) and Ian Franklin (London, UK) to look at the long-term impact of the COVID-19 crisis on the treatment...
Kathleen Gibson (Bellevue, USA) put the five-year data from the VeClose study, which looked at the treatment of patients with venous reflux in the great saphenous vein (GSV) with either the VenaSeal closure system (Medtronic) or radiofrequency ablation (RFA) therapy,...
Six venous specialists, Manj Gohel (Cambridge, UK), Ian Franklin (London, UK) Alun Davies (London, UK), Sriram Narayanan (Singapore), Raghu Kolluri (Columbus, USA) and Stephen Black (London, UK) discuss the role of telehealth during the COVID-19 crisis and beyond and...
Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes.
A number of recently...
This video is only available in selected geographies
Stephen Black (London, UK) talks to VEITHtv about how the dedicated venous open-cell nitinol Abre stent (Medtronic) compares with other venous nitinol stents available, noting that it is very easy to use,...
The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE.
Mark your calendars for this...
Manj Gohel (Cambridge, UK), one of the editors-in-chief of Venous News, introduces a special COVID-19 video with leading thrombosis and haemostasis experts, including Beverley Hunt (London, UK), Ian Franklin (London, UK), Francis Matthey (London, UK) and Sriram Narayanan (Singapore),...
Venous News filmed a panel discussion with Alun Davies (London, UK), Manj Gohel (Cambridge, UK) and Daniel Carradice (Hull, UK); who discussed treatment of venous ulceration and the randomised EVRA trial which, Carradice says, showed that early endovenous ablation of superficial venous...
Michael Lichtenberg (Arnsberg, Germany) talks to BLearning Venous at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the rationale behind his team’s study which looked at Intravascular ultrasound (IVUS) compared with fluoroscopic-guided recanalisation in patients with...
Raghu Kolluri (Columbus, USA) and John Kaufman (Portland, USA) talk to BLearning Venous about the highlights from The VEINS (Venous Endovascular INterventional Strategies) session at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA), as well as the...
Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to affect short-term and long-term outcomes such as cardiopulmonary health after PE needs “better characterisation”, Akhilesh...
David J. Dexter, (Sentara Healthcare, Norfolk, VA, USA), principal investigator of the CLOUT registry using the ClotTriever Mechanical Thrombectomy System (Inari Medical) for treatment of acute and chronic lower extremity DVT, presented the initial results for the first 50...
Suresh Vedantham (St Louis, USA) talks to BLearning Venous after winning the prestigious VEINS award at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about his current take on the open vein hypothesis and more.
Vedantham reflects on...
Sanjay Misra (Rochester, USA) talks to Interventional News about his research into whether stem cell therapy can help AVFs (arteriovenous fistulas) mature and also prevent venous stenosis. The pilot study with a small group of haemodialysis AVF patients led to “promising...
Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain.
Dake said: “The 24-month results from the VERNACULAR trial using the BD Venovo stent show absolutely sustained benefit in...
Karen Bauer (Toledo, USA) discusses the wound care limb salvage track at C3 which offered the “opportunity for clinicians from multiple disciplines to get together and talk about some really cutting-edge” topics.
Bauer, a wound specialist, says that at the...
Rabih Chaer (Pittsburgh, USA) talks to Venous News at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM; 12–15 June 2019, Washington, DC, USA)about the “need for dedicated venous stents” in the US in anticipation of the recently US FDA approved...
Steven Dubenec (Sydney, Australia) and Gerard O’Sullivan (Galway, Ireland) discuss the impact of dedicated venous stents, in particular the Venovo venous stent (BD, formerly Bard) at CX 2019.
Dubenec talks about how the Venovo stent – which comes in a...
Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at CX Live about the first ever iWounds workshop, the importance of wound management and what they hope to achieve.
Edmonds...
Michael D Dake (Tucson, USA) presented results from the VERNACULAR trial, which was designed to assess the performance of the Venovo venous stent (BD) for the treatment of iliac and femoral vein occlusions. At one year, the researchers found that the...
Mahmood Razavi (Orange, USA) reported new data from a subanalysis of the VIRTUS trial, which set out to investigate the safety and efficacy of the Vici stent (Boston Scientific). The subanalysis forms part of the first prospective multicentre corelab...
An analysis of ATTRACT has recently been published in the journal Circulation, in which the authors examine the effect of pharmacomechanical catheter-directed therapy (PCDT) in ATTRACT patients with iliofemoral deep vein thrombosis (DVT). As a result of this, Venous News spoke to...
Venous News arranged a roundtable with Sophie Renton (London, UK), Bruce Campbell (Exeter, UK) and Manj Gohel (Cambridge, UK), who called for more high quality, medium-to-long-term evidence to support the growing use of minimally invasive, but expensive, interventions for deep...
Kathleen Gibson (Bellevue, USA), one of the principal investigators of the SeCure trial, presented its results at the ACP 2018 annual congress. “More than closure rates, it is the quality of life findings from this trial that are important...
Rick de Graaf speaks to Venous News about complications from venous stenting, including causes and best treatment approaches for reinterventions after stenting.
Inferior vena cava (IVC) filters have long been a controversial topic, and some physicians have even called for a total moratorium on their implantation. Venous News spoke to John Kaufman (Portland, USA) at the 2017 Vascular Interventional Advances 2017...
Venous News caught up with Lars Rasmussen (Danish Vein Centres, Denmark) at the European Venous Forum (EVF; 29 June–1 July, Porto, Portugal) to hear about his five-year follow-up comparing endovenous radiofrequency ablation, laser ablation, foam sclerotherapy and surgical stripping...
At the European Venous Forum (EVF; 29 June–1 July, Porto, Portugal), Mattia Mirandola (Peschiera del Garda, Italy) presented his four-year experience of using ClariVein (Vascular Insights) for mechanochemical ablation of the saphenous vein. He shared his results with Venous...
Kathleen Gibson, Bellevue, USA, presented the three-year results of the VeClose clinical trial at the recent Charing Cross Symposium. Gibson spoke to Venous News about the study and about how she interprets the three-year data.
The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up with Raghu Kolluri (OhioHealth Vascular Institute, Columbus, USA) who explained his experience with the system...
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the CX...
This video tells the story of one of the world’s most prominent heart surgeons, Edward Diethrich, and the career-altering health issues he has faced as a result of chronic, low-level exposure to ionising radiation through his work.
https://youtu.be/rXgt0bF3GJM
Haroun Gajraj, director of the The VeinCare Centre, Bristol, UK, speaks about using medical super glue for the treatment of varicose veins and superficial venous reflux.
https://youtu.be/ac_om5HCjvg
